K. Shimoda et al. / Tetrahedron Letters 48 (2007) 1345–1347
1347
20. In order to obtain the products adequate for spectroscopic
analyses, the reaction was performed in a similar condition
to the standard assay system except that the scale was 10–
20-fold enlarged. Extraction from the reaction mixture
with ether followed by purification using column chroma-
tography on silica gel with pentane–ethyl acetate (95:5,
v/v) gave the products. Spectral data for the products.
Product 6a (obtained in the reduction of 1 with p51
reductase): HREIMS m/z 100.0252 [M]+; 1H NMR
(400 MHz, CDCl3) d 1.27 (3H, d, J = 7.2, CH3), 1.93
(1H, m, CH), 2.43–2.63 (2H, m, CH2), 4.17–4.37 (2H, m,
CH2); 13C NMR (100 MHz, CDCl3): d 14.7 (CH3), 30.3
(CH), 33.7 (CH2), 65.9 (CH2), 179.7 (C@O). Product 6b
(obtained in the reduction of 1 with p83 reductase):
HREIMS m/z 100.0255 [M]+; 1H and 13C NMR data were
entirely consistent with those for 6a. Product 7 (obtained
in the reduction of 2 with p51 reductase): HREIMS m/z
by reductases, which contracts the stereocenter remote
from the reaction center. Further studies on the whole
sequences of the reductases using molecular biological
techniques to clarify the role of the reductases in G.
max and to apply the expressed enzymes for large scale
synthesis of chiral butanolides are currently in progress.
References and notes
1. Leuenberger, G. W.; Boguth, W.; Barner, R.; Schmid, M.;
Zell, R. Helv. Chim. Acta 1979, 62, 455.
2. Shiuey, S. J.; Partridge, J. J.; Uskokovic, M. R. J. Org.
Chem. 1988, 53, 1040.
3. Dioubankova, N. N.; Malakhov, A. D.; Stetsenko, D. A.;
Korshun, V. A.; Gait, M. J. Org. Lett. 2002, 4, 4607.
4. Storer, R. I.; Takemoto, T.; Jackson, P. S.; Brown, D. S.;
Baxendale, I. R.; Ley, S. V. Chem. Eur. J. 2004, 10,
2529.
5. Rodeschini, V.; Boiteau, J. G.; Van, W. P.; Tarnus, C.;
Eustache, J. J. Org. Chem. 2004, 69, 357.
6. Yamamoto, K.; Nishioka, T.; Oda, J.; Yamamoto, Y.
Tetrahedron Lett. 1988, 29, 1717.
7. Yamamoto, Y.; Yamamoto, K.; Nishioka, T.; Oda, J.
Agric. Biol. Chem. 1988, 52, 3087.
8. Ozegowski, R.; Kunath, A.; Shick, H. J. Prakt. Chem.
1994, 544.
9. Ozegowski, R.; Kunath, A.; Shick, H. Liebigs Ann. Chem.
1994, 215.
10. Shieh, W.-R.; Gopalan, A. S.; Sih, C. J. J. Am. Chem. Soc.
1985, 107, 2993.
11. Keinan, E.; Hafeli, E. K.; Seth, K. K.; Lamed, R. J. Am.
Chem. Soc. 1986, 108, 162.
12. Kataoka, M.; Shimizu, S.; Doi, Y.; Sakamoto, K.;
Yamada, H. Biotechnol. Lett. 1990, 12, 357.
13. Nakamura, K.; Kondo, S.; Kawai, Y.; Ohno, A. Tetra-
hedron: Asymmetry 1993, 4, 1253.
14. Hirata, T.; Izumi, S.; Shimoda, K.; Hayashi, M. J. Chem.
Soc., Chem. Commun. 1993, 1426.
15. Shimoda, K.; Ito, D. I.; Izumi, S.; Hirata, T. J. Chem.
Soc., Perkin Trans. 1 1995, 355.
16. Shimoda, K.; Kubota, N. Tetrahedron: Asymmetry 2004,
15, 3827.
1
100.0251 [M]+; H NMR (400 MHz, CDCl3) d 1.15 (3H,
d, J = 6.8, CH3), 2.14–2.22 (2H, m, CH2), 2.60–2.69 (1H,
m, CH), 4.09–4.28 (2H, m, CH2); 13C NMR (100 MHz,
CDCl3): d 17.7 (CH3), 36.5 (CH), 37.2 (CH2), 69.9 (CH2),
180.1 (C@O). Product 8a (obtained in the reduction of 3
with p51 reductase): HREIMS m/z 114.0681 [M]+; 1H
NMR (400 MHz, CDCl3) d 1.16 (3H, d, J = 6.2 Hz, CH3),
1.24 (3H, d, J = 6.4 Hz, CH3), 1.91–2.27 (2H, m, 2CH),
3.73 (1H, t, J = 9.0 Hz, Ha–CH2), 4.36 (1H, t, J = 9.0, Hb–
CH2); 13C NMR (100 MHz, CDCl3): d 13.2 (CH3), 15.8
(CH3), 38.7 (CH), 41.6 (CH), 72.2 (CH2), 180.0 (C@O).
Product 8b (obtained in the reduction of 3 with p83
reductase): HREIMS m/z 114.0680 [M]+; 1H NMR
(400 MHz, CDCl3) d 0.95 (3H, d, J = 6.8 Hz, CH3), 1.10
(3H, d, J = 6.8 Hz, CH3), 2.52–2.65 (2H, m, 2CH), 3.87
(1H, d, J = 9.0 Hz, Ha–CH2), 4.24 (1H, dd, J = 9.0,
5.6 Hz, Hb–CH2); 13C NMR (100 MHz, CDCl3): d 9.8
(CH3), 13.2 (CH3), 33.7(CH), 38.1 (CH), 73.1 (CH2), 179.5
(C@O). Product 9 (obtained in the reduction of 4 with p83
reductase): HREIMS m/z 128.0837 [M]+; 1H NMR
(400 MHz, CDCl3) d 1.05 (3H, t, J = 6.4 Hz, CH3),
1.28–1.74 (4H, m, 2CH2), 2.11–2.72 (4H, m, 2CH2), 4.03
(1H, m, OCH); 13C NMR (100 MHz, CDCl3): d 14.0
(CH3), 27.5 (CH2), 33.6 (CH2), 35.5 (CH2), 36.9 (CH2),
87.2 (CH), 176.6 (C@O). Product 10 (obtained in the
reduction of 5 with p83 reductase): HREIMS m/z
1
142.0998 [M]+; H NMR (400 MHz, CDCl3) d 0.98 (3H,
t, J = 6.4 Hz, CH3), 1.31–1.73 (6H, m, 3CH2), 2.10–2.75
(4H, m, 2CH2), 4.01 (1H, m, OCH); 13C NMR (100 MHz,
CDCl3): d 13.9 (CH3), 22.5 (CH2), 27.9 (CH2), 33.5 (CH2),
36.3 (CH2), 37.1 (CH2), 87.0 (CH), 176.5 (C@O).
17. Takabe, K.; Tanaka, M.; Sugimoto, M.; Yamada, T.;
Yoda, H. Tetrahedron: Asymmetry 1992, 3, 1385.
18. Takabe, K.; Hiyoshi, H.; Sawada, H.; Tanaka, M.;
Miyazaki, A.; Yamada, T.; Katagiri, T.; Yoda, H.
Tetrahedron: Asymmetry 1992, 3, 1399.
21. Ng, G. S. Y.; Yuan, L.-C.; Jakovac, I. J.; Jones, J. B.
Tetrahedron 1984, 40, 1235.
22. Kawai, Y.; Hida, K.; Ohno, A. Bioorg. Chem. 1999, 27, 3.
19. Katoh, K.; Ishikawa, M.; Miyake, K.; Ohta, Y.; Hirose,
Y.; Iwamura, Y. Physiol. Plant. 1980, 49, 241.